Thomson Reuters Corp (TRI.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Thomson Reuters Corp (TRI.TO)

114.88

+0.01 (0.01%)

as of Jun 10, 2026, 7:17:58 pm Market Open.

214 watching

Investor Insights

Jun 9, 2026, 12:00 am

This summary was created by AI, based on 32 opinions in the last 12 months.

Thomson Reuters Corp (TRI-T) continues to evoke mixed opinions from experts, with many emphasizing its valuable proprietary data, especially for legal and accounting sectors. Some analysts recognize its potential to leverage AI technologies to enhance efficiency and product offerings. However, concerns around valuation persist, particularly with the stock's historical high PE ratios and recent downward trends. While there are varying perspectives on how AI may disrupt its core business, some analysts see TRI's unique data moat as a strong competitive advantage that may help it maintain resilience. Overall, while there are advocates for its long-term potential, there are also cautionary notes regarding its current market assessment and future revenue impacts from technological advancements.

Consensus

Hold

Valuation

Fair Value

Similar

Bloomberg, BDN

DON'T BUY

Has had 4% growth in earnings per share since 1989 with a decent dividend yield. Strong financial position. There has been a little bit of acceleration in growth recently but not big enough to indicate a change. Can do better elsewhere.

BUY

Has been in a very tight trading range for the last five years. The latest earnings release was quite a favorable surprise. Posted organic revenue growth in the 9% range which was well above expectations. Feels that it is finally starting to realise returns on all the investments it has made over the last five years.

TOP PICK

(A Top Pick Feb 14/06. Up 4.3%.) Thinks it is just beginning and will go higher. Is nervous about the market so wants to stay in something that is safe and secure. Has had some good, long bases.

TOP PICK

Had an interesting move recently. Has traded/fluctuated between $40/45 without making any headway. This pattern has gone on from October/03 giving it over 2 years of base building. Looks like it is on the verge of a breakout.

BUY

Has been in a trading range of $30/45 for a number of years. A great defensive stock. Has made a lot of investments to reorganise itself to be part of electronic data base management. Organic growth is coming in at 7/9%. Over 2% dividend yield.

WAIT

Interesting chart. It has a v-extended base. Wait for a break out, even if you have to pay $46.00

TOP PICK

Good solid company. He has liked it for a long time. They have come out with some good earnings and raised their dividends 10%. Free cash flow, before tax revisions were up 17%. A lot of their businesses are growing. Bought in Dec. at around $39.00. Looking for a number with a 5.

HOLD

Former top pick. It was a long term hold for this expert and is finally showing life. Expects it could increase by 10%. Entry should be around $40.00. Continue to hold.

TOP PICK

One of the top picks. Believes Thomson has been overlooked and its time has come. It has an extremely long base and it will probably go quite a ways if we get rotation of the commodities.

HOLD

3.3% dividend yield. They are doing all the right things, and yet the stock price is flat. Hopeful that it will be a turnaround. Management has done a good job.

DON'T BUY

Dead money.

HOLD

A lot of its business is US so when the Canadian dollar is strong, the stock in Canadian dollars is a little weak. They continue to report decent organic growth little by little. Looks a little expensive on a P/E basis. Thinks it should trade at $45/48. Patients will be rewarded.

BUY

Likes at this level. 2.3% yield and the company has a history of increasing diovidends. Multiples are more in line with its peer group. A good defensive stock.

BUY

Likes this company. Looks relatively expensive at 10 X cash flow, the fact is that the ROE is building from an extremely low level. Things are looking more positive. Have a good lock on the legal information market and are branching out into other areas.

DON'T BUY

They dominate the US market in legal information. Most of its earnings are in the US, so could have a currency risk. Stable dividend. Expect a slow growth rate in the single digit araea.

Showing 481 to 495 of 710 entries

Wealthica The ultimate 360° Tracker Your financial life in one place, automatically

Most Recent Experts

Kim Bolton

Black Swan Dexteritas

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

Barry Schwartz

Baskin Wealth Management

Jim Cramer - Mad Money

CNBC

Larry Berman CFA, CMT, CTA

ETF Capital Management Inc.

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Thomson Reuters Corp (TRI.TO)